Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study.
Lina Silva Salinas2022-07-28T09:41:48+02:00I. Noordhoek, E. Bastiaannet, N.A. de Glas, J. Scheepens, L.J. Esserman, J. Wesseling, A.N. Scholten, C.P. Schröder, S.G. Elias, J.R. Kroep, J.E.A. Portielje, M. Kleijn, G.J. Liefers. Published: July 21, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.07.006